General Information of the Compound
| Compound ID |
CP0395863
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-(4,6-diphenylpyrimidin-2-yl)propanamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
820961-64-6
BDBM50157663
CHEMBL222718
CTK3E2644
DTXSID70461023
N-(4,6-Diphenylpyrimidine-2-yl)propanamide
N-(4,6-diphenylpyrimidin-2-yl)propionamide
Propanamide, N-(4,6-diphenyl-2-pyrimidinyl)-
SCHEMBL6505603
ZINC13586469
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H17N3O
|
||||||||||||||||||
| Molecular Weight |
303.365
|
||||||||||||||||||
| Canonical SMILES |
CCC(=O)Nc1nc(cc(n1)-c1ccccc1)-c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H17N3O/c1-2-18(23)22-19-20-16(14-9-5-3-6-10-14)13-17(21-19)15-11-7-4-8-12-15/h3-13H,2H2,1H3,(H,20,21,22,23)
Show/Hide
|
||||||||||||||||||
| InChIKey |
AZXIPRTZIQWIHR-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00840, Adenosine receptor A1
Protein ID: PT00862, Adenosine receptor A2a
Protein ID: PT01278, Adenosine receptor A2b
Protein ID: PT01279, Adenosine receptor A3
Clinical Information about the Compound